| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Laboratory of Molecular Immunoregulation, National Cancer Institute, Frederick, MD 21702;
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140; and
Departments of Biological Chemistry and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287
Pain is one of the hallmarks of inflammation. Opioid receptors mediate antipain responses in both the peripheral nervous system and CNS. In the present study, pretreatment of CCR1:µ-opioid receptor/HEK293 cells with CCL3 (MIP-1
) induced internalization of µ-opioid receptors and severely impaired the µ-opioid receptor-mediated inhibition of cAMP accumulation. Immunohistochemical staining showed that CCR1 and µ-opioid receptors were coexpressed on small to medium diameter neurons in rat dorsal root ganglion. Analysis of ligand-induced calcium flux showed that both types of receptors were functional. Pretreatment of neurons with CCL3 exhibited an impaired [D-Ala2,N-MePhe4,Gly-o15]enkephalin-elicited calcium response, indicative of the heterologous desensitization of µ-opioid receptors. Other chemokines, such as CCL2, CCL5, and CXCL8, exhibited similar inhibitory effects. Our data indicate that proinflammatory chemokines are capable of desensitizing µ-opioid receptors on peripheral sensory neurons, providing a novel potential mechanism for peripheral inflammation-induced hyperalgesia.
This article has been cited by other articles:
|
|
 |
|
  K. Benamar, E. B. Geller, and M. W. Adler First in Vivo Evidence for a Functional Interaction between Chemokine and Cannabinoid Systems in the Brain J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 641 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lunzer, A. Yekkirala, R. P. Hebbel, and P. S. Portoghese Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia PNAS, April 3, 2007; 104(14): 6061 - 6065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Zozulya, E. Reinke, D. C. Baiu, J. Karman, M. Sandor, and Z. Fabry Dendritic Cell Transmigration through Brain Microvessel Endothelium Is Regulated by MIP-1{alpha} Chemokine and Matrix Metalloproteinases J. Immunol., January 1, 2007; 178(1): 520 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsuzaki, M. Canis, J.-L. Pouly, R. Botchorishvili, P.J. Dechelotte, and G. Mage Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis Hum. Reprod., January 1, 2007; 22(1): 124 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zhang, D. Yang, H. Dong, Q. Chen, D. I. Dimitrova, T. J. Rogers, M. Sitkovsky, and J. J. Oppenheim Adenosine A2a receptors induce heterologous desensitization of chemokine receptors Blood, July 1, 2006; 108(1): 38 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zhang and J. J. Oppenheim Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems J. Leukoc. Biol., December 1, 2005; 78(6): 1210 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Patwardhan, K. A. Berg, A. N. Akopain, N. A. Jeske, N. Gamper, W. P. Clarke, and K. M. Hargreaves Bradykinin-Induced Functional Competence and Trafficking of the {delta}-Opioid Receptor in Trigeminal Nociceptors J. Neurosci., September 28, 2005; 25(39): 8825 - 8832. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
